tm
Seeing Is Believing
tm
Seeing Is Believing
AXSM is currently covered by 15 analysts with an average price target of $262.68. This is a potential upside of $51.44 (26.27%) from yesterday's end of day stock price of $208.03.
Axsome Therapeutics's activity chart (see below) currently has 355 price targets and 311 ratings on display. The stock rating distribution of AXSM is 96.3% BUY and 3.7% HOLD.
Analysts average stock forecasts to be materialized ratio is 92.31% with an average time for these price targets to be met of 321.25 days.
Highest price target for AXSM is $316, Lowest price target is $205, average price target is $262.68.
Most recent stock forecast was given by GRAIG SUVANNAVEJH from MIZUHO on 12-Aug-2026. First documented stock forecast 19-May-2017.
Currently out of the existing stock ratings of AXSM, 52 are a BUY (96.3%), 2 are a HOLD (3.7%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Sep-2022
$316
$102.33 (47.89%)
$306
Buy Since 25-Jan-2024
$297
$83.33 (39.00%)
$304
Buy Since 03-Sep-2025
$256
$42.33 (19.81%)
$255
Buy Since 16-Oct-2019
$275
$61.33 (28.70%)
$260
Hold Since 05-May-2026
$251
$37.33 (17.47%)
$242
What is AXSM (Axsome Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AXSM (Axsome Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AXSM (Axsome Therapeutics)?
Which analyst is the currently most bullish on AXSM (Axsome Therapeutics)?
Which analyst is the currently most reserved on AXSM (Axsome Therapeutics)?
